13 research outputs found
The Path to Eliminating Raccoon Rabies in the Eastern US-Obstacles and Opportunities in Urban-Suburban Landscapes
Rabies in terrestrial wildlife poses a significant public and animal health threat. Oral rabies vaccination (ORV) targeting specific vector species has proven effective in eliminating certain rabies variants in Europe and Canada. The goal of eliminating the raccoon rabies variant (RRV) in the US is achievable through an integrated ORV program at the landscape scale. Current wildlife rabies management in the US includes extensive air and ground ORV programs in 16 eastern states coordinated by Wildlife Services (WS)’ National Rabies Management Program. More than 10 million vaccine-baits are distributed annually targeting raccoons (Procyon lotor) and striped skunks (Mephitis mephitis) with the long-term goal of eliminating RRV. Achieving vaccine-induced herd immunity in target species in developed landscapes has proven challenging due to abundant anthropogenic food sources, higher wildlife densities, decreased home ranges, habitat fragmentation, and non-target bait competition. Effectively managing RRV in the urban-suburban landscape requires greater understanding of meso-carnivore ecology in these landscapes and critical analyses of current baiting strategies. Preliminary results from urban-suburban studies demonstrate fewer potential ORV bait encounters for target species than expected, lower seroconversion rates compared to rural habitats and patchy bait distribution patterns. New technologies including the use of Point of Interest GPS units to document ground bait distribution in combination with research conducted by WS including ORV field trials, urban density studies, and raccoon, skunk, and opossum (Didelphis virginiana) ecology have provided valuable insight to overcome the obstacles of urban rabies management and make eliminating RRV a reality
Recommended from our members
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders
Funder: Kennedy Trust Rheumatology Research Prize StudentshipFunder: DFG Cluster of Excellence “Precision Medicine in Chronic In-flammation” (PMI; ID: EXC2167)Funder: EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: “Ideas” Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013)); doi: https://doi.org/10.13039/100011199; Grant(s): 715772Funder: NWO-VIDI grant 016.178.056, the Netherlands Heart Foundation CVON grant 2018-27, and NWO Gravitation grant ExposomeNLFunder: Li Ka Shing Foundation (Li Ka Shing Foundation Limited); doi: https://doi.org/10.13039/100007421Abstract: Irritable bowel syndrome (IBS) results from disordered brain–gut interactions. Identifying susceptibility genes could highlight the underlying pathophysiological mechanisms. We designed a digestive health questionnaire for UK Biobank and combined identified cases with IBS with independent cohorts. We conducted a genome-wide association study with 53,400 cases and 433,201 controls and replicated significant associations in a 23andMe panel (205,252 cases and 1,384,055 controls). Our study identified and confirmed six genetic susceptibility loci for IBS. Implicated genes included NCAM1, CADM2, PHF2/FAM120A, DOCK9, CKAP2/TPTE2P3 and BAG6. The first four are associated with mood and anxiety disorders, expressed in the nervous system, or both. Mirroring this, we also found strong genome-wide correlation between the risk of IBS and anxiety, neuroticism and depression (rg > 0.5). Additional analyses suggested this arises due to shared pathogenic pathways rather than, for example, anxiety causing abdominal symptoms. Implicated mechanisms require further exploration to help understand the altered brain–gut interactions underlying IBS